Take action by following the link at the end of this post to prevent the FDA from removing your access to sustained-release T3.  The Senate Committee on Health, Education, Labor, and Pensions (HELP) has released draft legislation that would enable the FDA to regulate both compounding pharmacies and the compounded medications themselves. Currently compounding pharmacies are regulated on the state level.  Page 7 of the draft says: “may include the designation of drugs or categories of drugs that present demonstrable difficulties for compounding, such as extended release products….”  As it turns out, extended release products are not difficult to compound.  And, if you weren’t able to get sustained-release T3 from a compounding pharmacist you wouldn’t be able to get it anywhere because drug companies don’t make it.  But even the medical literature states that sustained-release T3 is the safer,  preferred way for delivering T3.  If you are a resident of  AK, CT, CO, GA, IL, IA, KS, KY, MD, MA, MN, NC, PA, RI, SC, TN, UT, VT, WA, WI, or WY then please contact your member of the Senate HELP Committee by CLICKING HERE and ask him to strike the extreme language that will discontinue access to sustained-release T3 and other useful medicines that are available in no other way. CLICK HERE